The current standard for treatment of hyperglycemia in women with pre-gestational diabetes (PGDM) involves intensive insulin therapy; occasionally, oral hypoglycemic agents, a change of diet, and close monitoring of blood glucose are recommended in women with T1D, T2D, or GDM. This evidence concerns the gene INS and gestational diabetes.